Literature DB >> 27377099

Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.

Ia Hultman1, Charlotta Vedin1, Anna Abrahamsson1, Susanne Winiwarter1, Malin Darnell1.   

Abstract

Design of slowly metabolized compounds is an important goal in many drug discovery projects. Standard hepatocyte suspension intrinsic clearance (CLint) methods can only provide reliable CLint values above 2.5 μL/min/million cells. A method that permits extended incubation time with maintained performance and metabolic activity of the in vitro system is warranted to allow in vivo clearance predictions and metabolite identification of slowly metabolized drugs. The aim of this study was to evaluate the static HμREL coculture of human hepatocytes with stromal cells to be set up in-house as a standard method for in vivo clearance prediction and metabolite identification of slowly metabolized drugs. Fourteen low CLint compounds were incubated for 3 days, and seven intermediate to high CLint compounds and a cocktail of cytochrome P450 (P450) marker substrates were incubated for 3 h. In vivo clearance was predicted for 20 compounds applying the regression line approach, and HμREL coculture predicted the human intrinsic clearance for 45% of the drugs within 2-fold and 70% of the drugs within 3-fold of the clinical values. CLint values as low as 0.3 μL/min/million hepatocytes were robustly produced, giving 8-fold improved sensitivity of robust low CLint determination, over the cutoff in hepatocyte suspension CLint methods. The CLint values of intermediate to high CLint compounds were at similar levels both in HμREL coculture and in freshly thawed hepatocytes. In the HμREL coculture formation rates for five P450-isoform marker reactions, paracetamol (CYP1A2), 1-OH-bupropion (CYP2B6), 4-OH-diclofenac (CYP2C9), and 1-OH-midazolam (3A4) were within the range of literature values for freshly thawed hepatocytes, whereas 1-OH-bufuralol (CYP2D6) formation rate was lower. Further, both phase I and phase II metabolites were detected and an increased number of metabolites were observed in the HμREL coculture compared to hepatocyte suspension. In conclusion, HμREL coculture can be applied to accurately estimate intrinsic clearance of slowly metabolized drugs and is now utilized as a standard method for in vivo clearance prediction of such compounds in-house.

Entities:  

Keywords:  HμREL coculture; P450 activity; clearance prediction; low CLint; metabolite formation; slowly metabolized drugs

Mesh:

Substances:

Year:  2016        PMID: 27377099     DOI: 10.1021/acs.molpharmaceut.6b00396

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  14 in total

1.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

2.  Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Authors:  Paul Morgan; Dean G Brown; Simon Lennard; Mark J Anderton; J Carl Barrett; Ulf Eriksson; Mark Fidock; Bengt Hamrén; Anthony Johnson; Ruth E March; James Matcham; Jerome Mettetal; David J Nicholls; Stefan Platz; Steve Rees; Michael A Snowden; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2018-01-19       Impact factor: 84.694

Review 3.  Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group Survey.

Authors:  Carl Petersson; Xin Zhou; Joerg Berghausen; David Cebrian; Michael Davies; Kevin DeMent; Peter Eddershaw; Arian Emami Riedmaier; Alix F Leblanc; Nenad Manveski; Punit Marathe; Panteleimon D Mavroudis; Robin McDougall; Neil Parrott; Andreas Reichel; Charles Rotter; David Tess; Laurie P Volak; Guangqing Xiao; Zheng Yang; James Baker
Journal:  AAPS J       Date:  2022-07-19       Impact factor: 3.603

Review 4.  Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

Authors:  Jasleen K Sodhi; Leslie Z Benet
Journal:  J Med Chem       Date:  2021-03-25       Impact factor: 7.446

5.  Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds.

Authors:  Lena C Preiss; Volker M Lauschke; Katrin Georgi; Carl Petersson
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

6.  Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.

Authors:  Jaydeep Yadav; Mehdi El Hassani; Jasleen Sodhi; Volker M Lauschke; Jessica H Hartman; Laura E Russell
Journal:  Drug Metab Rev       Date:  2021-05-25       Impact factor: 6.984

7.  Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.

Authors:  Benjamin R Taft; Fumiaki Yokokawa; Tom Kirrane; Anne-Catherine Mata; Richard Huang; Nicole Blaquiere; Grace Waldron; Bin Zou; Oliver Simon; Subramanyam Vankadara; Wai Ling Chan; Mei Ding; Sandra Sim; Judith Straimer; Armand Guiguemde; Suresh B Lakshminarayana; Jay Prakash Jain; Christophe Bodenreider; Christopher Thompson; Christian Lanshoeft; Wei Shu; Eric Fang; Jafri Qumber; Katherine Chan; Luying Pei; Yen-Liang Chen; Hanna Schulz; Jessie Lim; Siti Nurdiana Abas; Xiaoman Ang; Yugang Liu; Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Francisco Javier Gamo; Benigno Crespo-Fernandez; Philip J Rosenthal; Roland A Cooper; Patrick Tumwebaze; Anna Caroline Campos Aguiar; Brice Campo; Simon Campbell; Jürgen Wagner; Thierry T Diagana; Christopher Sarko
Journal:  J Med Chem       Date:  2022-03-01       Impact factor: 8.039

8.  Long-term hepatitis B infection in a scalable hepatic co-culture system.

Authors:  Benjamin Y Winer; Tiffany S Huang; Eitan Pludwinski; Brigitte Heller; Felix Wojcik; Gabriel E Lipkowitz; Amit Parekh; Cheul Cho; Anil Shrirao; Tom W Muir; Eric Novik; Alexander Ploss
Journal:  Nat Commun       Date:  2017-07-25       Impact factor: 14.919

Review 9.  Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.

Authors:  Yitian Zhou; Joanne X Shen; Volker M Lauschke
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

Review 10.  A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.

Authors:  Ana S Serras; Joana S Rodrigues; Madalena Cipriano; Armanda V Rodrigues; Nuno G Oliveira; Joana P Miranda
Journal:  Front Cell Dev Biol       Date:  2021-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.